FDA Releases Blueprint to Expand Animal Drug Development for Minor Uses and Minor Species 

June 30, 2026

The U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) today released its MUMS Blueprint for Success: 2026-2028, a three-year strategic plan to modernize and expand the Minor Use and Minor Species (MUMS) program. The Blueprint outlines future FDA actions and proposals to improve the availability of safe and effective drugs for underserved animal populations – minor animal species, such as sheep, goats, fish, and exotic species, as well as major animal species like cattle, dogs, cats, and chickens, affected with uncommon diseases for which few or no drugs currently exist.